Continuous subcutaneous insulin infusion (CSII) versus multiple daily injections (MDI) of rapid-acting insulin analogues and detemir in type 1 diabetic (T1D) pregnant women

2014 ◽  
Vol 28 (3) ◽  
pp. 276-280 ◽  
Author(s):  
Giorgio Mello ◽  
Sara Biagioni ◽  
Serena Ottanelli ◽  
Camilla Nardini ◽  
Zelinda Tredici ◽  
...  
2013 ◽  
Vol 53 (2) ◽  
pp. 130-135 ◽  
Author(s):  
Ewa Wender-Ozegowska ◽  
Agnieszka Zawiejska ◽  
Katarzyna Ozegowska ◽  
Katarzyna Wroblewska-Seniuk ◽  
Rafal Iciek ◽  
...  

2010 ◽  
Vol 12 (4) ◽  
pp. 263-269 ◽  
Author(s):  
Stella González-Romero ◽  
Inmaculada González-Molero ◽  
Micaela Fernández-Abellán ◽  
Marta E. Domínguez-López ◽  
Soledad Ruiz-de-Adana ◽  
...  

2013 ◽  
Vol 68 (10) ◽  
pp. 675-677 ◽  
Author(s):  
Ewa Wender-Ozegowska ◽  
Agnieszka Zawiejska ◽  
Katarzyna Ozegowska ◽  
Katarzyna Wroblewska-Seniuk ◽  
Rafal Iciek ◽  
...  

2014 ◽  
Vol 2014 ◽  
pp. 1-6 ◽  
Author(s):  
Chun-xiu Gong ◽  
Li-ya Wei ◽  
Di Wu ◽  
Bing-yan Cao ◽  
Xi Meng ◽  
...  

Aims. To determine whether multiple daily injections (MDIs) or continuous subcutaneous insulin infusion (CSII) contributes to better glucose control in children with different type 1 diabetes duration.Methods. Subjects were grouped according to early (≤1 year after disease onset; 1A) or late (1–3 years after onset; 2A) MDIs/CSII treatment initiation. Corresponding control groups (1B, 2B) received insulin injections twice daily.Results. HbA1c levels were consistently lower in group 1A than in group 1B (6 months (T2): 7.37% versus 8.21%; 12 months (T3): 7.61% versus 8.41%; 24/36 months (T4/T5): 7.61% versus 8.72%; allP<0.05), but were lower in group 2A than in group 2B only at T2 (8.36% versus 9.19%;P=0.04). Levels were lower in group 1A than in group 2A when disease duration was matched (7.61% versus 8.49%;P<0.05). Logistic regression revealed no correlation between HbA1c level and MDIs/CSII therapy. HbA1c levels were only negatively related to insulin dosage.Conclusions. Blood glucose control was better in patients receiving MDIs/CSII than in those receiving conventional treatment. Early MDIs/CSII initiation resulted in prolonged maintenance of low HbA1c levels compared with late initiation. MDIs/CSII therapy should be combined with comprehensive management.


2019 ◽  
Vol 90 (3) ◽  
pp. 154-160
Author(s):  
Urszula Mantaj ◽  
Pawel Gutaj ◽  
Katarzyna Ozegowska ◽  
Agnieszka Zawiejska ◽  
Katarzyna Wroblewska-Seniuk ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document